https://www.selleckchem.com/pr....oducts/sbi-0640756.h
f closely related histocompatible donor material. Patients with post-transplant cytopenias due to poor graft function or primary engraftment failure show poor prognosis with a high mortality rate mainly because of graft host disease (GVHD), infection and/or bleeding. Treatment options are scarce and a CD34+ stem cell boost or a second bone marrow transplantation may be required to restore adequate haematopoiesis. In the present study patients with primary engraftment failure ( = 1) and refractory poor graft function ( = 11) were t
Like
Comment
Share
